Drug development and manufacturing accelerator Quotient Sciences has announced major changes to its commercial and scientific executive leadership team.   New appointments include Dr. Andrew Lewis as Chief Scientific Officer, Kieron Hall as Chief Marketing Officer, and Eric Bironneau as Chief Business Officer. Dr. Andrew Lewis In his new role as Chief Scientific Officer, Dr. Andrew Lewis has responsibility for the company’s scientific and technological innovation. Lewis will lead the team...